HILL INTERNATIONAL INC (HIL)

US4314661012 - Common Stock

3.4  +0.02 (+0.59%)

Fundamental Rating

2

Overall HIL gets a fundamental rating of 2 out of 10. We evaluated HIL against 82 industry peers in the Professional Services industry. HIL has a bad profitability rating. Also its financial health evaluation is rather negative. HIL is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year HIL was profitable.
HIL had a negative operating cash flow in the past year.
In multiple years HIL reported negative net income over the last 5 years.
In multiple years HIL reported negative operating cash flow during the last 5 years.

1.2 Ratios

The profitability ratios for HIL are negative, so there is not much use analyzing them.
Looking at the Return On Invested Capital, with a value of 6.55%, HIL is in line with its industry, outperforming 43.94% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HIL is below the industry average of 11.79%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.81%
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 3.21%, HIL is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
HIL does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 3.21%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HIL is still creating some value.
The number of shares outstanding for HIL has been increased compared to 1 year ago.
The debt/assets ratio for HIL is higher compared to a year ago.

2.2 Solvency

HIL has an Altman-Z score of 2.12. This is not the best score and indicates that HIL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.12, HIL is not doing good in the industry: 65.15% of the companies in the same industry are doing better.
HIL has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
HIL has a Debt to Equity ratio of 0.30. This is comparable to the rest of the industry: HIL outperforms 54.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.78
WACC8.37%

2.3 Liquidity

A Current Ratio of 1.59 indicates that HIL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.59, HIL perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
A Quick Ratio of 1.59 indicates that HIL should not have too much problems paying its short term obligations.
HIL has a Quick ratio (1.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59

2

3. Growth

3.1 Past

HIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1729382256910270464.00%, which is quite impressive.
Looking at the last year, HIL shows a quite strong growth in Revenue. The Revenue has grown by 8.58% in the last year.
The Revenue has been decreasing by -6.06% on average over the past years.
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-120%
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y-6.06%
Revenue growth Q2Q13.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 113.33, which means the current valuation is very expensive for HIL.
Compared to the rest of the industry, the Price/Earnings ratio of HIL indicates a slightly more expensive valuation: HIL is more expensive than 77.27% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of HIL to the average of the S&P500 Index (28.11), we can say HIL is valued expensively.
Industry RankSector Rank
PE 113.33
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.95

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HILL INTERNATIONAL INC

NYSE:HIL (12/23/2022, 7:04:00 PM)

3.4

+0.02 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap194.10M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 113.33
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 3.21%
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y